Bradykardizující léky v terapii pacientů po infarktu myokardu

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Heart rate slowing drugs in the treatment of myocardial infarction survivors
Authors	VÍTOVEC Jiří ŠPINAR Jindřich
Year of publication	2009
Type	Article in Periodical
Magazine / Source	Cor et Vasa
MU Faculty or unit	Faculty of Medicine
Citation
Field	Cardiovascular diseases incl. cardiosurgery
Keywords	Heart rate; Digoxin; Betablockers; Verapamil;Diltiazem; Ivabradine; Secondary prevention after MI
Description	The authors present a review of heart rate slowing drugs given to myocardial infarction survivors, including digoxin as an inotrope, beta blockers reducing sympathetic activity, calcium channel blockers such as verapamil, diltiazem with their vasodilator action, and the sinus node inhibitor ivabradine, which is currently undergoing clinical trials. The article discusses current concepts and lists indications for their use in secondary prevention in patients after myocardial infarction.
Related projects:	Early diagnostics and treatment of cardiovascular diseases